Viewing Study NCT04380805


Ignite Creation Date: 2025-12-25 @ 3:09 AM
Ignite Modification Date: 2025-12-31 @ 10:40 PM
Study NCT ID: NCT04380805
Status: COMPLETED
Last Update Posted: 2025-02-28
First Post: 2020-05-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer
Sponsor: Akeso
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module